BioengineeringbioRxivPreprint
Human iPSC-CMs and in-silico technologies define mechanisms and accelerate targeted pharmacogenetics in hypertrophic cardiomyopathy
F. Margara, Y. Psaras, Z. J. Wang…·A. Bueno-Orovio
The paper combines human iPSC-CMs and in-silico models to identify genotype-specific pathomechanisms and therapeutic targets in hypertrophic cardiomyopathy.